[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2022 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- -9.81%
YoY- 10.9%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 735,982 735,366 643,786 604,088 591,704 514,500 480,710 7.35%
PBT 89,610 96,238 86,746 74,236 74,204 52,340 49,528 10.38%
Tax -19,266 -23,034 -20,738 -17,656 -17,442 -10,368 -11,118 9.59%
NP 70,344 73,204 66,008 56,580 56,762 41,972 38,410 10.60%
-
NP to SH 70,344 73,204 66,008 56,580 56,762 41,972 38,434 10.59%
-
Tax Rate 21.50% 23.93% 23.91% 23.78% 23.51% 19.81% 22.45% -
Total Cost 665,638 662,162 577,778 547,508 534,942 472,528 442,300 7.04%
-
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 9,577 9,468 7,061 6,843 13,237 8,399 13,947 -6.07%
Div Payout % 13.62% 12.93% 10.70% 12.10% 23.32% 20.01% 36.29% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
NOSH 961,942 952,239 706,330 684,383 661,881 650,902 278,959 22.90%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 9.56% 9.95% 10.25% 9.37% 9.59% 8.16% 7.99% -
ROE 10.49% 11.54% 10.74% 9.73% 11.28% 19.99% 8.30% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 76.84 77.67 91.17 88.27 89.40 183.76 172.32 -12.58%
EPS 7.36 7.76 9.34 8.26 8.52 6.44 13.76 -9.89%
DPS 1.00 1.00 1.00 1.00 2.00 3.00 5.00 -23.51%
NAPS 0.70 0.67 0.87 0.85 0.76 0.75 1.66 -13.39%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 76.51 76.45 66.93 62.80 61.51 53.49 49.97 7.35%
EPS 7.31 7.61 6.86 5.88 5.90 4.36 4.00 10.56%
DPS 1.00 0.98 0.73 0.71 1.38 0.87 1.45 -6.00%
NAPS 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 0.4814 6.35%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 1.30 1.20 3.03 1.62 1.37 1.30 2.25 -
P/RPS 1.69 1.55 3.32 1.84 1.53 0.71 1.31 4.33%
P/EPS 17.70 15.52 32.41 19.60 15.98 8.67 16.33 1.35%
EY 5.65 6.44 3.09 5.10 6.26 11.53 6.12 -1.32%
DY 0.77 0.83 0.33 0.62 1.46 2.31 2.22 -16.17%
P/NAPS 1.86 1.79 3.48 1.91 1.80 1.73 1.36 5.35%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 -
Price 1.19 1.34 2.49 3.15 1.41 1.08 2.03 -
P/RPS 1.55 1.73 2.73 3.57 1.58 0.59 1.18 4.64%
P/EPS 16.20 17.33 26.64 38.10 16.44 7.20 14.73 1.59%
EY 6.17 5.77 3.75 2.62 6.08 13.88 6.79 -1.58%
DY 0.84 0.75 0.40 0.32 1.42 2.78 2.46 -16.38%
P/NAPS 1.70 2.00 2.86 3.71 1.86 1.44 1.22 5.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment